Sanjeev Narula

Chief Financial Officer

Professional Overview
Sanjeev Narula is an accomplished finance executive with over 15 years of experience leading financial operations and strategic decision-making in the pharmaceutical industry. As the Chief Financial Officer at Intra-Cellular Therapies, he is responsible for overseeing the company's financial strategy, driving operational efficiencies, and supporting the development and commercialization of innovative therapies.

Experience Summary

Current Role
As the Chief Financial Officer at Intra-Cellular Therapies, Sanjeev is responsible for managing the company's financial operations, including budgeting, forecasting, and reporting. He plays a key role in strategic planning, capital allocation, and risk management, ensuring the organization's financial health and supporting its growth initiatives. Sanjeev's leadership and financial expertise have been instrumental in Intra-Cellular Therapies' pursuit of new drug approvals and successful product launches.

Career Progression
Prior to his current role, Sanjeev held the position of Chief Financial Officer at Viatris, where he was instrumental in the successful integration of Mylan and Pfizer's Upjohn division. Before that, he served as the Chief Financial Officer and Senior Vice President of Finance and Business Operations for the Pfizer Upjohn Division, as well as the Chief Financial Officer for Pfizer's Essential Health business unit. Throughout his career, Sanjeev has demonstrated a strong track record of driving financial performance, optimizing business operations, and contributing to the overall strategic direction of the organizations he has served.

Academic Background
Sanjeev holds a Bachelor of Commerce degree from the University of Delhi and is a Certified Public Accountant (CPA) and Chartered Global Management Accountant (CGMA).

Areas of Expertise

• Financial planning and analysis

• Capital allocation and investment strategy

• Mergers, acquisitions, and integrations

• Business performance optimization

• Financial reporting and compliance

• Risk management and internal controls

Professional Impact
Sanjeev's leadership and strategic financial expertise have played a pivotal role in the success of the organizations he has served. At Viatris, he led the integration of Mylan and Pfizer's Upjohn division, driving synergies and operational efficiencies that contributed to the company's improved financial performance. In his previous roles at Pfizer, Sanjeev's contributions included the implementation of robust financial systems, the optimization of global shared services, and the development of innovative financing strategies to support the company's growth initiatives.

Conclusion
Sanjeev Narula is a seasoned finance executive with a proven track record of driving financial excellence and strategic decision-making in the pharmaceutical industry. As the Chief Financial Officer at Intra-Cellular Therapies, he is poised to continue his success, leveraging his deep expertise to support the company's ongoing growth and the development of life-changing therapies.